股票代码：******
网站地图
News & Information
Product Center
2.5 mL, 10,000 IU per vial
Indication (summary): For tetanus prophylaxis; where tetanus or suspected symptoms are present, use with appropriate surgical management.
0.75 mL, 1,500 IU per vial
Indication (summary): For tetanus prophylaxis; where tetanus or suspected symptoms are present, use with appropriate surgical management.
Business Map
Note: The map is only used to show the business situation and does not represent any position
Manufacturing Technology
We operate a modern, automated, GMP‑compliant biopharmaceutical platform. Every step follows GMP specifications. While introducing advanced technologies and equipment to improve efficiency, we uphold our mission of “making quality medicines for people worldwide,” building a complete production and quality‑management system for full‑process control and safe delivery of medicines.
Comprehensive quality‑management system
Full‑process risk‑assurance system
Fully intelligent production system
About Us
Jiangxi Institute of Biological Products Inc. was founded in 1969 as the Jiangxi branch of Shanghai Institute of Biological Products under the Ministry of Health, with over fifty years of biopharmaceutical history. In 2002 it was converted into a limited liability company and further converted into a joint‑stock limited company in December 2017. The company now owns eight wholly owned subsidiaries across China and is a National High‑tech Enterprise dedicated to the research, development, production and sales of antitoxins and immune‑serum biological products. We built the first GMP‑compliant biopharmaceutical filling platform for antiserum that uses isolator‑based aseptic filling; established in Zhangye, Gansu, China’s largest GMP‑compliant horse‑breeding and plasma‑collection base; in Chifeng, Inner Mongolia, the country’s first and largest companion‑plasma preparation platform compliant with Veterinary GMP; in Shenzhen, an integrated collaboration platform spanning production, academia, research, clinical services, and CRO for drug clinical trials; and in Hainan, a pharmaceutical R&D technology service platform to efficiently integrate high‑quality global resources.
High‑tech Enterprise
Industry‑leading enterprise
Proprietary patented technologies
50+ years of pharmaceutical experience
Products exported to 30+ countries and regions
R&D Innovation
We view R&D and innovation as the foundation of development. Over more than 50 years, we have prioritized building our R&D capabilities. Through continuous talent recruitment, we have formed a research team led by post‑doctoral and doctoral scientists and established deep collaborations with leading universities, and set up Jiangxi Postdoctoral Innovation and Practice Base with multiple projects progressing orderly. Each year we invest tens of millions of RMB in R&D. We have set up R&D centers and scientific platforms in Jiangxi, Shenzhen, Inner Mongolia, Guizhou, Gansu, and Hainan, equipped with complete laboratories and analytical/inspection instruments. Our affiliated R&D bases are outfitted with advanced specialized equipment, enabling multiple new products to scale from research to industrial production. With accumulated know‑how, we have obtained 48 patents and received honors such as Provincial Enterprise Technology Center, Jiangxi High‑tech Enterprise, and National High‑tech Enterprise.
Ongoing Projects
Antivenom serum project
Anti‑rabies serum research project
Other ongoing projects
Laboratories & Equipment
Total Organic Carbon (TOC) analyzer
Atomic absorption spectrometer
High‑performance liquid chromatograph
Micro‑spectrophotometer
Particle Detector
Corporate Culture
Jiangsheng Industrial Cluster
Chifeng Bo-en Pharmaceutical Co., Ltd.
A technology‑driven manufacturer focused on biopharmaceuticals and chemical pharmaceuticals; main products include animal‑derived therapeutics such as tetanus antitoxin serum and equine chorionic gonadotropin (eCG).
Gaotai County Tianhong Biochemical Technology Development Co., Ltd.
A high‑tech private enterprise integrating horse breeding, immunization for biomedicine, and plasma separation/purification, with China’s largest GMP‑compliant horse‑breeding base.
Learn more
Jiangsheng (Shenzhen) Biotechnology R&D Center Co., Ltd.
A biomedicine R&D organization focusing on immunology, vaccinology, and genetic engineering; research areas include clinical immunology, laboratory medicine, basic biology, glycomics, proteomics, genetic engineering, molecular immunology, and human genomics.
Learn more
Hainan Pharmaceutical Research Institute Co., Ltd.
Engaged in pharmaceutical research, testing/inspection, animal studies, and non‑clinical safety evaluation; CMA‑certified and designated for duties such as capsule quality monitoring and GLP safety assessment. Holds ~1,400 testing qualifications across 13 categories including drugs and medical devices.
Add:
Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China
Board Office:
Complaint & Report Hotline:
Pharmacovigilance Hotline:
Company Email:
Investor Relations:
International Sales Email:
Complaint/Report Email:
WeChat mini-site
WeChat official account
© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO
Powered by www.300.cn